ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,508Medicare Part D Prescriptions Filled, Including Refills

Rank: 734 out of 2888

$373K Total Retail Price of All Prescriptions

Rank: 1183 out of 2888

436 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 436 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 8,266 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCHLOROTHIAZIDE 460 447 1 15
SIMVASTATIN 434 431 2 2
LEVOTHYROXINE SODIUM 433 420 3 1
AMLODIPINE BESYLATE 370 360 4 5
LISINOPRIL 358 351 5 3
ATENOLOL 274 254 6 25
HYDROCODONE-ACETAMINOPHEN 236 206 S3 7 4
METOPROLOL TARTRATE 224 217 8 10
ATORVASTATIN CALCIUM 176 172 9 9
LOVASTATIN 170 170 10 41
POTASSIUM CHLORIDE 168 161 11 14
METFORMIN HCL 163 155 12 8
FUROSEMIDE 149 144 13 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 121 116 14 28
SERTRALINE HCL 118 117 15 27
OMEPRAZOLE 117 114 16 7
LOSARTAN POTASSIUM 117 117 16 18
PRAVASTATIN SODIUM 116 112 18 12
ZOLPIDEM TARTRATE 107 94 19 17
GLYBURIDE 93 93 R 20 58
TRAMADOL HCL 89 85 21 16
AMOXICILLIN 88 88 22 117
LOSARTAN-HYDROCHLOROTHIAZIDE 86 78 23 46
ALLOPURINOL 82 82 24 37
NEXIUM 80 78 25 19
FLUTICASONE PROPIONATE 75 73 26 32
ENALAPRIL MALEATE 70 70 27 49
CITALOPRAM HBR 70 70 27 24
GABAPENTIN 69 69 29 13
DOXAZOSIN MESYLATE 67 67 30 94
NAMENDA 66 66 31 34
TRIAMTERENE-HCTZ 66 66 31 63
CLONIDINE HCL 57 57 33 39
LIPITOR 56 56 34 78
OXYBUTYNIN CHLORIDE 55 55 35 124
CIPROFLOXACIN HCL 55 55 35 47
SYNTHROID 53 49 37 52
PAROXETINE HCL 53 49 37 84
DIOVAN HCT 51 51 39 61
CARVEDILOL 51 50 39 21
AMITRIPTYLINE HCL 51 51 R 39 74
METOPROLOL SUCCINATE 50 50 42 11
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.